GSKH vs. PBPH

Last updated Jun 26, 2026

GSKH (GSK plc ADRhedged ETF) and PBPH (Portfolio Building Block World Pharma and Biotech Index ETF) are both Health & Biotech Equities funds - GSKH tracks the GSK plc Local Shares Total Return while PBPH tracks the BITA Global Pharma and Biotech Select Index. Both are passively managed. A 0.64 correlation means they provide meaningful diversification when combined. GSKH charges 0.19%/yr vs 0.13%/yr for PBPH.

Performance

GSKH vs. PBPH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in GSK plc ADRhedged ETF (GSKH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, GSKH achieves a 9.31% return, which is significantly higher than PBPH's 4.70% return.

GSKH

• 1D: 0.80%
• 1M: 2.24%
• YTD: 9.31%
• 6M: 9.50%
• 1Y: 43.24%
• 3Y*: —
• 5Y*: —
• 10Y*: —

PBPH

• 1D: 1.26%
• 1M: 3.55%
• YTD: 4.70%
• 6M: 3.79%
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

GSKH vs. PBPH - Yearly Performance Comparison

	2026 (YTD)	2025
GSKH GSK plc ADRhedged ETF	9.31%	1.25%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	4.70%	0.74%

Correlation

The correlation between GSKH and PBPH is 0.64, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.

	Correlation
Correlation (All Time) Calculated using the full available price history since Nov 25, 2025	0.64

Return for Risk

GSKH vs. PBPH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

GSKH

GSKH Risk / Return Rank: 52
GSKH Sharpe Ratio Rank: 54
GSKH Sortino Ratio Rank: 57
GSKH Omega Ratio Rank: 55
GSKH Calmar Ratio Rank: 53
GSKH Martin Ratio Rank: 41

PBPH

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

GSKH vs. PBPH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for GSK plc ADRhedged ETF (GSKH) and Portfolio Building Block World Pharma and Biotech Index ETF (PBPH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	GSKH	PBPH	Difference
Sharpe ratio: Return per unit of total volatility	1.66	—	—
Sortino ratio: Return per unit of downside risk	2.45	—	—
Omega ratio: Gain probability vs. loss probability	1.31	—	—
Calmar ratio: Return relative to maximum drawdown	2.34	—	—
Martin ratio: Return relative to average drawdown	6.07	—	—

Drawdowns

GSKH vs. PBPH - Drawdown Comparison

The maximum GSKH drawdown since its inception was -18.54%, which is greater than PBPH's maximum drawdown of -11.10%. Use the drawdown chart below to compare losses from any high point for GSKH and PBPH.

Drawdown Indicators

	GSKH	PBPH	Difference
Max Drawdown Largest peak-to-trough decline	-18.54%	-11.10%	-7.44%
Max Drawdown (1Y) Largest decline over 1 year	-18.54%	—	—
Current Drawdown Current decline from peak	-12.10%	-3.31%	-8.79%
Average Drawdown Average peak-to-trough decline	-5.90%	-4.35%	-1.55%
Ulcer Index Depth and duration of drawdowns from previous peaks	7.15%	—	—

Volatility

Volatility by Period

	GSKH	PBPH	Difference
Volatility (1M) Calculated over the trailing 1-month period	7.07%	—	—
Volatility (6M) Calculated over the trailing 6-month period	18.72%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	26.18%	17.05%	+9.13%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	26.91%	17.05%	+9.86%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	26.91%	17.05%	+9.86%

GSKH vs. PBPH - Expense Ratio Comparison

GSKH has a 0.19% expense ratio, which is higher than PBPH's 0.13% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.

Dividends

GSKH vs. PBPH - Dividend Comparison

GSKH's dividend yield for the trailing twelve months is around 2.84%, more than PBPH's 0.09% yield.

Position	TTM	2025
GSKH GSK plc ADRhedged ETF	2.84%	1.15%
PBPH Portfolio Building Block World Pharma and Biotech Index ETF	0.09%	0.09%

Frequently Asked Questions

Can I hold both GSKH and PBPH in my portfolio?

GSKH and PBPH have a correlation of 0.64, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which ETF is better, GSKH or PBPH?

On fees, PBPH is cheaper at 0.13% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, GSKH or PBPH?

PBPH is cheaper with a 0.13% expense ratio, compared with 0.19% for GSKH.

Which ETF pays a higher dividend yield, GSKH or PBPH?

GSKH has the higher dividend yield at 2.84%, compared with 0.09% for PBPH.

What is the main difference between GSKH and PBPH?

GSKH tracks GSK plc Local Shares Total Return, while PBPH tracks BITA Global Pharma and Biotech Select Index. They also come from different issuers: ADRhedged and Portfolio Building Block. Their fees differ too: 0.19% for GSKH and 0.13% for PBPH.